Buccal Drug Delivery System Market Report 2026: Strategic Insights and Revenue Outlook
Uncover key drivers, emerging technologies, and competitive movements shaping the semiconductor timing integrated circuit (ic) market from 2026–2035 with trusted insights from The Business Research Company
How is the Buccal Drug Delivery System Market size predicted to change over the forecast window of 2026–2035?_x000D_
The buccal drug delivery system market has experienced substantial expansion in recent years. This market is projected to expand from $3.89 billion in 2025 to $4.32 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.2%. Historically, this growth stemmed from a heightened preference for alternative drug delivery methods, an increase in treatments for chronic pain and angina, developments in mucoadhesive formulations, a greater need for medications with quicker onset, and the expansion of oral pharmaceutical production._x000D_
_x000D_
The buccal drug delivery system market is expected to experience significant growth in the coming years, with forecasts showing it will reach $6.48 billion by 2030, at a compound annual growth rate (CAGR) of 10.7%. This expansion is attributed to various factors including increased investments in transmucosal drug research, a rising demand for smoking cessation therapies, the broader adoption of personalized drug delivery systems, an intensified focus on compliance-friendly formulations, and the accelerated development of novel buccal drugs. Throughout the forecast period, key trends are set to include the wider acceptance of buccal and sublingual dosage forms, a growing need for rapid drug absorption systems, a greater emphasis on patient-friendly drug delivery, the enlargement of controlled-release buccal formulations, and an enhanced focus on non-invasive therapies._x000D_
_x000D_
#Access Your Free Sample Report for In-Depth Market Insights:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=8290&type=smp_x000D_
_x000D_
Which Drivers Are Contributing To The Expansion Of The Buccal Drug Delivery System Market?_x000D_
The rising incidence of chronic diseases is anticipated to fuel the expansion of the buccal drug delivery systems market moving forward. Chronic diseases are defined as ailments that persist for a minimum of a year, encompassing conditions such as cancer, heart disease, stroke, diabetes, and arthritis. These prevalent, incurable illnesses necessitate continuous medical care and nutritional support for management. For numerous patients battling chronic conditions like diabetes and cancer, buccal drug delivery systems provide an appropriate and efficient means for administering required mucosal and transmucosal drugs. For example, data from June 2024 released by the National Health Service, a UK-based government department, revealed that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition characterized by elevated blood sugar levels, insufficient for a diabetes diagnosis) in 2023. This marked an 18% surge from 3,065,825 cases recorded in 2022. Consequently, the increasing prevalence of chronic diseases drives the growth of the buccal drug delivery systems market._x000D_
_x000D_
What Segment Classifications Make Up The Buccal Drug Delivery System Market?_x000D_
The buccal drug delivery system market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Sublingual, Buccal Tablets And Lozenges, Oral Sprays_x000D_
2) By Application: Pain Management, Smoking Cessation, Angina Pectoris_x000D_
3) By End-User: Hospitals, Ambulatory Centers, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Sublingual: Sublingual Tablets, Sublingual Films_x000D_
2) By Buccal Tablets And Lozenges: Buccal Tablets, Buccal Lozenges_x000D_
3) By Oral Sprays: Spray Solutions, Spray Gels_x000D_
_x000D_
Which Market Trends Are Opening Growth Opportunities In The Buccal Drug Delivery System Market?_x000D_
Leading companies active in the buccal drug delivery systems market are emphasizing new product introductions, such as melatonin oral spray, to boost their market revenues. Melatonin oral spray is a type of melatonin supplement designed for oral administration in a spray form. For example, in February 2023, Arlak Biotech Private Limited, an India-based pharmaceutical firm, unveiled its melatonin oral spray. This spray assists the body’s natural melatonin production, thus enhancing sleep quality through a convenient and effective method. The medication offers a rapid remedy for individuals struggling to fall asleep, stay asleep, or adjust to various sleep patterns. Its quick and simple oral absorption facilitates a faster onset of sleep and improved sleep quality._x000D_
_x000D_
Which Key Players Are Driving Competition In The Buccal Drug Delivery System Market?_x000D_
Major companies operating in the buccal drug delivery system market are Teva Pharmaceuticals Industries Ltd, Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior PLC, Generex Biotechnology Corporation, Catalent Inc, Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd, AstraZeneca PLC, Dr. Reddy’s Laboratories Ltd, Takeda Pharmaceutical Company Limited, Novartis AG, Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc, NAPP Pharmaceutical Ltd, Perrigo Company PLC, Reckitt Benckiser Group PLC, Teligent Pharma Inc, Par Pharmaceutical Companies Inc, Acorda Therapeutics Inc, Opiant Pharmaceuticals Inc _x000D_
_x000D_
#Access The Complete Report For Deeper Market Insights:#_x000D_
_x000D_
Which Region Is Projected To Lead The Buccal Drug Delivery System Market During The Forecast Period?_x000D_
North America was the largest region in the buccal drug delivery systems market share in 2025. The regions covered in the buccal drug delivery system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Request Your Customized Buccal Drug Delivery System Market Research Report for Competitive Advantage:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=8290&type=smp_x000D_
_x000D_
#Browse Through More Reports Similar to the Global Buccal Drug Delivery System Market 2026, By The Business Research Company#_x000D_
_x000D_
Gastroretentive Drug Delivery Systems Outsourcing Global Market Report 2026_x000D_
_x000D_
Pharmaceutical Drug Delivery Global Market Report 2026_x000D_
_x000D_
Advanced Drug Delivery Systems Global Market Report 2026_x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_